Lodge BA - Search Results

1

Identification of Histoplasma capsulatum from culture extracts by real-time PCR.

Martagon-Villamil J, Shrestha N, Sholtis M, Isada CM, Hall GS, Bryne T, Lodge BA, Reller LB, Procop GW. Martagon-Villamil J, et al. Among authors: lodge ba. J Clin Microbiol. 2003 Mar;41(3):1295-8. doi: 10.1128/JCM.41.3.1295-1298.2003. J Clin Microbiol. 2003. PMID: 12624071 Free PMC article.

2

Aspergillus fumigatus empyema, arthritis, and calcaneal osteomyelitis in a lung transplant patient successfully treated with posaconazole.

Lodge BA, Ashley ED, Steele MP, Perfect JR. Lodge BA, et al. J Clin Microbiol. 2004 Mar;42(3):1376-8. doi: 10.1128/JCM.42.3.1376-1378.2004. J Clin Microbiol. 2004. PMID: 15004125 Free PMC article.

3

Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates.

Zaas AK, Boyce M, Schell W, Lodge BA, Miller JL, Perfect JR. Zaas AK, et al. Among authors: lodge ba. J Clin Microbiol. 2003 Nov;41(11):5233-5. doi: 10.1128/JCM.41.11.5233-5235.2003. J Clin Microbiol. 2003. PMID: 14605170 Free PMC article.

4

Biotransformation of tri-substituted methoxyamphetamines by Cunninghamella echinulata.

Foster BC, McLeish J, Wilson DL, Whitehouse LW, Zamecnik J, Lodge BA. Foster BC, et al. Among authors: lodge ba. Xenobiotica. 1992 Dec;22(12):1383-94. doi: 10.3109/00498259209056689. Xenobiotica. 1992. PMID: 1494884

5

Discriminative stimulus properties of substituted amphetamine derivatives.

Corrigall WA, Coen KM, Saouda FM, Robertson JM, Lodge BA. Corrigall WA, et al. Among authors: lodge ba. Pharmacol Biochem Behav. 1992 Dec;43(4):1117-9. doi: 10.1016/0091-3057(92)90490-7. Pharmacol Biochem Behav. 1992. PMID: 1475294

6

The reinforcing and discriminative stimulus properties of para-ethoxy- and para-methoxyamphetamine.

Corrigall WA, Robertson JM, Coen KM, Lodge BA. Corrigall WA, et al. Among authors: lodge ba. Pharmacol Biochem Behav. 1992 Jan;41(1):165-9. doi: 10.1016/0091-3057(92)90077-s. Pharmacol Biochem Behav. 1992. PMID: 1539067

7

Effects of chronic treatment of rats with "designer" amphetamines on brain regional monoamines.

Martin-Iverson MT, Lodge BA. Martin-Iverson MT, et al. Among authors: lodge ba. Can J Physiol Pharmacol. 1991 Dec;69(12):1825-32. doi: 10.1139/y91-270. Can J Physiol Pharmacol. 1991. PMID: 1802356

8

Canadian designer drugs.

Lodge BA. Lodge BA. J Psychiatry Neurosci. 1991 Dec;16(5):239-40. J Psychiatry Neurosci. 1991. PMID: 1797097 Free PMC article. No abstract available.

9

"Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment.

Martin-Iverson MT, Yamada N, By AW, Lodge BA. Martin-Iverson MT, et al. Among authors: lodge ba. J Psychiatry Neurosci. 1991 Dec;16(5):253-61. J Psychiatry Neurosci. 1991. PMID: 1686728 Free PMC article.

10

Biotransformation of 2-, 3-, and 4-methoxy-amphetamines by Cunninghamella echinulata.

Foster BC, Litster DL, Lodge BA. Foster BC, et al. Among authors: lodge ba. Xenobiotica. 1991 Oct;21(10):1337-46. doi: 10.3109/00498259109043208. Xenobiotica. 1991. PMID: 1796610

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page